These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 33021411)
1. Frequent loss of BTG1 activity and impaired interactions with the Caf1 subunit of the Ccr4-Not deadenylase in non-Hodgkin lymphoma. Almasmoum HA; Airhihen B; Seedhouse C; Winkler GS Leuk Lymphoma; 2021 Feb; 62(2):281-290. PubMed ID: 33021411 [TBL] [Abstract][Full Text] [Related]
2. The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex. Doidge R; Mittal S; Aslam A; Winkler GS PLoS One; 2012; 7(12):e51331. PubMed ID: 23236473 [TBL] [Abstract][Full Text] [Related]
3. A conserved motif in human BTG1 and BTG2 proteins mediates interaction with the poly(A) binding protein PABPC1 to stimulate mRNA deadenylation. Amine H; Ripin N; Sharma S; Stoecklin G; Allain FH; Séraphin B; Mauxion F RNA Biol; 2021 Dec; 18(12):2450-2465. PubMed ID: 34060423 [TBL] [Abstract][Full Text] [Related]
4. The enzyme activities of Caf1 and Ccr4 are both required for deadenylation by the human Ccr4-Not nuclease module. Maryati M; Airhihen B; Winkler GS Biochem J; 2015 Jul; 469(1):169-76. PubMed ID: 25944446 [TBL] [Abstract][Full Text] [Related]
5. CNOT7 Outcompetes Its Paralog CNOT8 for Integration into The CCR4-NOT Complex. Stoney PN; Yanagiya A; Nishijima S; Yamamoto T J Mol Biol; 2022 May; 434(9):167523. PubMed ID: 35248544 [TBL] [Abstract][Full Text] [Related]
6. Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex. Rouault JP; Prévôt D; Berthet C; Birot AM; Billaud M; Magaud JP; Corbo L J Biol Chem; 1998 Aug; 273(35):22563-9. PubMed ID: 9712883 [TBL] [Abstract][Full Text] [Related]
7. The Ccr4-NOT deadenylase subunits CNOT7 and CNOT8 have overlapping roles and modulate cell proliferation. Aslam A; Mittal S; Koch F; Andrau JC; Winkler GS Mol Biol Cell; 2009 Sep; 20(17):3840-50. PubMed ID: 19605561 [TBL] [Abstract][Full Text] [Related]
8. Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway. Prévôt D; Morel AP; Voeltzel T; Rostan MC; Rimokh R; Magaud JP; Corbo L J Biol Chem; 2001 Mar; 276(13):9640-8. PubMed ID: 11136725 [TBL] [Abstract][Full Text] [Related]
9. Tumor suppressors BTG1 and BTG2: Beyond growth control. Yuniati L; Scheijen B; van der Meer LT; van Leeuwen FN J Cell Physiol; 2019 May; 234(5):5379-5389. PubMed ID: 30350856 [TBL] [Abstract][Full Text] [Related]
10. Emerging role of anti-proliferative protein BTG1 and BTG2. Kim SH; Jung IR; Hwang SS BMB Rep; 2022 Aug; 55(8):380-388. PubMed ID: 35880434 [TBL] [Abstract][Full Text] [Related]
11. Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement. Hata K; Nishijima K; Mizuguchi J Exp Cell Res; 2007 Jul; 313(11):2356-66. PubMed ID: 17466295 [TBL] [Abstract][Full Text] [Related]
12. Discovery of Substituted 5-(2-Hydroxybenzoyl)-2-Pyridone Analogues as Inhibitors of the Human Caf1/CNOT7 Ribonuclease. Kaur I; Jadhav GP; Fischer PM; Winkler GS Molecules; 2024 Sep; 29(18):. PubMed ID: 39339346 [TBL] [Abstract][Full Text] [Related]
13. The BTG2 protein is a general activator of mRNA deadenylation. Mauxion F; Faux C; Séraphin B EMBO J; 2008 Apr; 27(7):1039-48. PubMed ID: 18337750 [TBL] [Abstract][Full Text] [Related]
14. Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton. Tijchon E; van Ingen Schenau D; van Opzeeland F; Tirone F; Hoogerbrugge PM; Van Leeuwen FN; Scheijen B PLoS One; 2015; 10(7):e0131481. PubMed ID: 26218146 [TBL] [Abstract][Full Text] [Related]
15. Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity. Yang X; Morita M; Wang H; Suzuki T; Yang W; Luo Y; Zhao C; Yu Y; Bartlam M; Yamamoto T; Rao Z Nucleic Acids Res; 2008 Dec; 36(21):6872-81. PubMed ID: 18974182 [TBL] [Abstract][Full Text] [Related]
16. Structural Model of the Human BTG2-PABPC1 Complex by Combining Mutagenesis, NMR Chemical Shift Perturbation Data and Molecular Docking. Ameerul A; Almasmoum H; Pavanello L; Dominguez C; Winkler GS J Mol Biol; 2022 Jul; 434(14):167662. PubMed ID: 35640718 [TBL] [Abstract][Full Text] [Related]
17. BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation. Stupfler B; Birck C; Séraphin B; Mauxion F Nat Commun; 2016 Feb; 7():10811. PubMed ID: 26912148 [TBL] [Abstract][Full Text] [Related]
18. Polyubiquitination of the B-cell translocation gene 1 and 2 proteins is promoted by the SCF ubiquitin ligase complex containing βTrCP. Sasajima H; Nakagawa K; Kashiwayanagi M; Yokosawa H Biol Pharm Bull; 2012; 35(9):1539-45. PubMed ID: 22975506 [TBL] [Abstract][Full Text] [Related]
19. Essential functions of the CNOT7/8 catalytic subunits of the CCR4-NOT complex in mRNA regulation and cell viability. Mostafa D; Takahashi A; Yanagiya A; Yamaguchi T; Abe T; Kureha T; Kuba K; Kanegae Y; Furuta Y; Yamamoto T; Suzuki T RNA Biol; 2020 Mar; 17(3):403-416. PubMed ID: 31924127 [TBL] [Abstract][Full Text] [Related]
20. The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation. Prévôt D; Voeltzel T; Birot AM; Morel AP; Rostan MC; Magaud JP; Corbo L J Biol Chem; 2000 Jan; 275(1):147-53. PubMed ID: 10617598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]